Polish biotech firms surge on PARP grant approvals

Multiple Polish listed biotech and medical companies, including Ryvu and Scope Fluidics, announced their projects were placed on the ranking list for co-financing from the Polish Agency for Enterprise Development (PARP). Shares of these companies rose on the news. The grants provide non-dilutive funding, boosting near-term liquidity and validating project viability, though the exact amounts and final award terms remain to be confirmed.